Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Healthequity (HQY) over the last 7 years, with Q4 2025 value amounting to $982.1 million.

  • Healthequity's Non-Current Debt fell 915.18% to $982.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $982.1 million, marking a year-over-year decrease of 915.18%. This contributed to the annual value of $1.1 billion for FY2025, which is 2072.4% up from last year.
  • Per Healthequity's latest filing, its Non-Current Debt stood at $982.1 million for Q4 2025, which was down 915.18% from $1.0 billion recorded in Q3 2025.
  • Healthequity's 5-year Non-Current Debt high stood at $1.1 billion for Q3 2024, and its period low was $872.9 million during Q2 2023.
  • Moreover, its 5-year median value for Non-Current Debt was $920.3 million (2022), whereas its average is $946.7 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 2205.05% in 2021, then surged by 2607.87% in 2024.
  • Over the past 5 years, Healthequity's Non-Current Debt (Quarter) stood at $923.5 million in 2021, then dropped by 1.31% to $911.4 million in 2022, then decreased by 4.07% to $874.3 million in 2023, then increased by 23.65% to $1.1 billion in 2024, then decreased by 9.15% to $982.1 million in 2025.
  • Its Non-Current Debt stands at $982.1 million for Q4 2025, versus $1.0 billion for Q3 2025 and $1.1 billion for Q2 2025.